Naschitz Anat 4
4 · 89bio, Inc. · Filed Jul 14, 2020
Insider Transaction Report
Form 4
89bio, Inc.ETNB
Naschitz Anat
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-06-22+7,000→ 7,000 total(indirect: See footnote)Exercise: $24.29Exp: 2030-06-22→ Common Stock (7,000 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, which will vest in full on June 22, 2021, subject to the Reporting Person's continued service to the Issuer through such date.
- [F2]These securities are held of record by Anat Naschitz ("Naschitz"), an employee of OrbiMed Advisors Israel II Limited ("Israel II Limited"). Pursuant to an agreement between Israel II Limited, OrbiMed Israel GP II, L.P. ("Israel II GP"), OrbiMed Advisors LLC ("OrbiMed Advisors"), and OrbiMed Capital GP VI LLC ("GP VI"), Naschitz is obligated to transfer these securities, or the economic benefit thereof, to Israel II Limited, Israel II GP, OrbiMed Advisors, and GP VI, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP and OrbiMed Israel Partners II, L.P.